Intellipharmaceutics International (IPCIF) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free IPCIF Stock Alerts $0.06 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | americanbankingnews.comIntellipharmaceutics International (OTCMKTS:IPCIF) Stock Price Passes Above 200-Day Moving Average of $0.06March 6, 2024 | finanznachrichten.deIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Cease Trade OrderFebruary 28, 2024 | ca.finance.yahoo.comIntellipharmaceutics International Inc. (IPCI.TO)February 8, 2024 | finance.yahoo.comIntellipharmaceutics International Inc. Announces Stock Option GrantJanuary 2, 2024 | finance.yahoo.comIntellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture ExchangeOctober 16, 2023 | finanznachrichten.deIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2023 ResultsJuly 14, 2023 | finance.yahoo.comIntellipharmaceutics Announces Second Quarter 2023 ResultsJune 27, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Monday (IPCI)June 10, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Friday (IPCI)June 6, 2023 | msn.comIntellipharmaceutics International reports FY 2022 and Q1 2023 resultsJune 6, 2023 | finance.yahoo.comIntellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 ResultsMay 10, 2023 | thestreet.comJim Cramer -- International Paper, United Technologies Looking More AttractiveApril 12, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Tuesday (IPCI)April 11, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Thursday (IPCI)March 17, 2023 | seekingalpha.comIPCIF Intellipharmaceutics International Inc.March 7, 2023 | finance.yahoo.comIntellipharmaceutics Announces Cease Trade OrderFebruary 6, 2023 | finance.yahoo.comIntellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order ApplicationOctober 15, 2022 | finanznachrichten.deIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2022 ResultsOctober 14, 2022 | finance.yahoo.comIntellipharmaceutics Announces Third Quarter 2022 ResultsJuly 15, 2022 | finance.yahoo.comIntellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022February 28, 2022 | finance.yahoo.comIntellipharmaceutics Announces Fiscal Year 2021 ResultsJanuary 13, 2022 | finance.yahoo.comIntellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene KeirsteadDecember 22, 2021 | finance.yahoo.comIntellipharmaceutics Comments on Recent Trading ActivityOctober 16, 2021 | finanznachrichten.deIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2021 ResultsOctober 13, 2021 | businesswire.comKim Spencer McPhee Barristers, P.C. Publishes This Notice of Settlement Approval of the Intellipharmaceutics International Inc. Securities Class Action Get Intellipharmaceutics International News Delivered to You Automatically Sign up to receive the latest news and ratings for IPCIF and its competitors with MarketBeat's FREE daily newsletter. Email Address get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land. Click here to see my #1 investment for 2024. IPCIF Media Mentions By Week IPCIF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPCIF News Sentiment▼0.000.49▲Average Medical News Sentiment IPCIF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPCIF Articles This Week▼00▲IPCIF Articles Average Week Get Intellipharmaceutics International News Delivered to You Automatically Sign up to receive the latest news and ratings for IPCIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GLMD News Today ALLR News Today QLGN News Today CNSP News Today CMND News Today BPTH News Today DRMA News Today PRFX News Today ATXI News Today ATNF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IPCIF) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
